UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022789
Receipt number R000026235
Scientific Title Evaluation of kinds of taste damaged by cord blood cell transplantation
Date of disclosure of the study information 2016/08/01
Last modified on 2019/10/08 16:34:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of kinds of taste damaged by cord blood cell transplantation

Acronym

Evaluation of kinds of taste damaged by cord blood cell transplantation

Scientific Title

Evaluation of kinds of taste damaged by cord blood cell transplantation

Scientific Title:Acronym

Evaluation of kinds of taste damaged by cord blood cell transplantation

Region

Japan


Condition

Condition

hematologic malignancies before hematopoietic stem cell transplantion

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Investigation of kinds of taste damaged by cord blood cell transplantation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Taste perception before and 4 weeks after hematopoietic stem cell transplantation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

definition of kinds of taste using by paper filters

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Adults who are going to take cord blood stem cell transplantation

Key exclusion criteria

Those who've got chemotherapy or stem cell transplantation before.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Mieko
Middle name
Last name Mizutani

Organization

Toranomon Hospital

Division name

Dentistry

Zip code

105-0001

Address

2-2-2, Toranomon, Minato-Ku, Tokyo

TEL

0335881111

Email

m.mizutani@toranomon.gr.jp


Public contact

Name of contact person

1st name Mieko
Middle name
Last name Mizutani

Organization

Toranomon Hospital

Division name

Division of Dentistry

Zip code

105-0001

Address

2-2-2, Toranomon, Minato-Ku, Tokyo

TEL

0335881111

Homepage URL


Email

m.mizutani@toranomon.gr.jp


Sponsor or person

Institute

Toranomon Hospital

Institute

Department

Personal name



Funding Source

Organization

Toranomon Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toranomon Hospital

Address

2-2-2 Toranomon, Minato-ku

Tel

0335881111

Email

m.mizutani@toranomon.gr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions




Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 01 Day

Date of IRB

2016 Year 08 Month 08 Day

Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 19 Day

Last modified on

2019 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026235


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name